Balyasny Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-100,680
| Closed | -$16.6M | – | 2317 |
|
|
2021
Q2 | $16.6M | Sell |
100,680
-128,821
| -56% | -$21.3M | 0.08% | 310 |
|
|
2021
Q1 | $35.2M | Buy |
229,501
+225,340
| +5,416% | +$34.6M | 0.17% | 123 |
|
|
2020
Q4 | $522K | Sell |
4,161
-3,749
| -47% | -$470K | ﹤0.01% | 971 |
|
|
2020
Q3 | $802K | Sell |
7,910
-29,497
| -79% | -$2.99M | 0.01% | 825 |
|
|
2020
Q2 | $3.64M | Buy |
37,407
+23,204
| +163% | +$2.26M | 0.03% | 488 |
|
|
2020
Q1 | $1.18M | Buy |
+14,203
| New | +$1.18M | 0.01% | 611 |
|
|
2019
Q3 | – | Sell |
-24,270
| Closed | -$2.41M | – | 1568 |
|
|
2019
Q2 | $2.41M | Sell |
24,270
-13,613
| -36% | -$1.35M | 0.02% | 696 |
|
|
2019
Q1 | $4.18M | Buy |
37,883
+30,825
| +437% | +$3.4M | 0.03% | 538 |
|
|
2018
Q4 | $649K | Sell |
7,058
-42,350
| -86% | -$3.89M | ﹤0.01% | 932 |
|
|
2018
Q3 | $5.44M | Sell |
49,408
-41,797
| -46% | -$4.61M | 0.02% | 532 |
|
|
2018
Q2 | $8.52M | Sell |
91,205
-10,951
| -11% | -$1.02M | 0.04% | 444 |
|
|
2018
Q1 | $8.48M | Sell |
102,156
-148,800
| -59% | -$12.3M | 0.04% | 487 |
|
|
2017
Q4 | $22.9M | Buy |
250,956
+35,712
| +17% | +$3.25M | 0.07% | 326 |
|
|
2017
Q3 | $16.4M | Buy |
215,244
+57,831
| +37% | +$4.4M | 0.06% | 314 |
|
|
2017
Q2 | $11.8M | Buy |
157,413
+26,713
| +20% | +$2M | 0.05% | 421 |
|
|
2017
Q1 | $8.53M | Sell |
130,700
-76,712
| -37% | -$5M | 0.04% | 479 |
|
|
2016
Q4 | $11.4M | Buy |
207,412
+23,580
| +13% | +$1.3M | 0.06% | 364 |
|
|
2016
Q3 | $10.4M | Buy |
+183,832
| New | +$10.4M | 0.06% | 373 |
|